Approved? (Admin-only)
  • Approved
Opportunity TypePre-Announcement
Funding Opportunity Posted ByDOW
ComponentDHA - CDMRP
Funding Opportunity TitleMilitary Burn Research Program
Link to Funding Opportunityhealth.mil
Funding Opportunity Short DescriptionTo support innovative, high-impact research with clinical relevance that will support military-relevant burn trauma care.
Funding Opportunity CategoryHealth and Biomedical Technologies
Important Dates
Funding Details
Required Registrations
  • SAM
  • GRANTS
  • eBRAP
Funding Opportunity Full Description

(1) Discovery Award (2) Technology/Therapeutic Development Award (3) Patient Centered Research Award

The FY26 Defense Appropriations Act provides funding for the MBRP to support innovative, high-impact research with clinical relevance that will support military-relevant burn trauma care. As part of the DHA R&D-MRDC, the CDMRP is the program office managing these anticipated FY26 funding opportunities.

The MBRP provides the information in this pre-announcement to allow investigators time to plan and develop ideas for submission to the anticipated FY26 funding opportunities. Investigators should not construe this pre-announcement as an obligation or promise by the government. The CDMRP will post FY26 MBRP funding opportunity announcements on the Grants.gov website. Once released, the funding opportunity announcements will include pre-application and application deadlines.

Applications submitted to the FY26 MBRP must address one or more of the following focus areas:

-Development and/or validation of methods to triage, treat and/or prevent complications of cold injury
-Research to innovate best practices in the acute burn care continuum in a combat setting
-Development and/or validation of methods for use in a combat setting to prevent, assess and/or treat burn injury-related complications, including:
-Over or under fluid resuscitation
-Endotheliopathy
-Sepsis
-Inhalation injuries
-Fungal infections
-Hypermetabolism
-Early, acute phase interventions that reduce later development of chronic pain, neuropathy, pruritus and temperature dysregulation. Studies must provide preliminary evidence for long-term effectiveness.

Type your search here